32.30SEK+0.31%Mkt Cap: 50.36M $P/E: —Today
FluoGuide A/S, a clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark. The company offers FG001, an urokinase-type plasminogen activator receptor target imaging agent, which is in …
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap50.36M $
Enterprise Value46.98M $
Revenue (TTM)22.77K $
Gross Profit22.77K $
Net Income (TTM)-3.77M $
Revenue/Share0.0015 USD
Last Price32.30 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees6
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-5.19
PEG—
EV/EBITDA-11.37
EV/Revenue2063.59
P/S2211.97
P/B12.21
EPS (TTM)-4.25
EPS (Forward)-6.21
52W Range
31.1032% of range34.90
52W High34.90 SEK
52W Low31.10 SEK
Profitability
Gross Margin100.00%
Oper. Margin-24590.74%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-72.36%
ROA-44.69%
Growth
Revenue Growth50.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.54M $
CapEx (TTM)—
FCF Margin-11529.52%
FCF Yield-5.21%
Net Debt-3.38M $
Net Debt/EBITDA0.82
Balance Sheet
Debt/Equity0.52
Current Ratio13.70
Quick Ratio13.12
Book Value/Sh2.638 SEK
Cash/Share3.868 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating0.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)59.36 SEK
Upside (mean)+83.8%
Target Range45.15 SEK – 73.57 SEK
SEK45.15+83.8% to meanSEK73.57
# Analysts2
Ownership
Shares Out.16.35M
Float—
Insiders24.94%
Institutions10.47%
Technical
SMA 5036.59 (-11.7%)
SMA 20037.53 (-13.9%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)2.90K
Avg Vol (10d)4.72K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—